Obstructive sleep apnea severity and pathophysiological traits in overlap syndrome: Insights from the SNOOzzzE cohort
Year: 2025
Type: article
Study design: Observational Study
Abstract: The overlap syndrome ( OVS ), defined as coexisting chronic obstructive pulmonary disease ( COPD ) and obstructive sleep apnea ( OSA ), is linked to worse outcomes than either condition alone. Patients with COPD and OSA may have fewer obstructive events, but underlying mechanisms remain unclear. Using a large clinical cohort, we tested the hypothesis that OSA severity and pathophysiological traits differ in OVS versus OSA ‐alone. Data from the SNOOzzzE cohort (3319 adults with in‐laboratory polysomnography 2017–2019) were used. OVS patients were identified through chart review and matched to OSA ‐only patients (3:1) by age, sex, and body mass index. OSA severity was assessed using apnea hypopnea index ( AHI ), hypoxic burden ( HB ), and T90 (%time with SpO 2 < 90%), while OSA traits were quantified from polysomnographic signals via validated algorithms. Mixed model analysis quantified group differences before and after adjustment for covariate differences (Black race, smoking) accounting for matching as a random effect. In our diverse cohort (103 OVS vs. 309 OSA‐only; 38% women, 44% non‐White, 17% Hispanic), OVS patients tended to have a lower AHI and HB (approximately −10%, p < 0.1), but significantly higher T90 (~50%, p = 0.003). OVS patients had less upper airway collapsibility, lower arousal threshold, lower ventilatory response to arousal ( p < 0.05) and tended to have higher upper airway dilator muscle compensation ( p = 0.09). In adjusted analyses, effect estimates were similar, but significance was attenuated. Hyperinflation and air trapping were inversely associated with AHI / HB . OSA severity and mechanisms differ in OVS versus OSA ‐only. Future research should seek to evaluate these differences for their prognostic ability.
Source: Physiological Reports
DOI: 10.14814/phy2.70438
Institutions: University of California San Diego, Hospital Universitario de La Princesa, Apnimed (United States), Universidad Autónoma de Madrid, Brigham and Women's Hospital, Harvard University, Universidad de Zaragoza, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,050
Funders: American Heart Association, Fundación Alfonso Martín Escudero, Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences, NHLBI Division of Intramural Research
Awards: G1110505228, G1363921473, G1568512157, G1570615896, Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease, G2105566936, Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea, G2928778974, G4459328136, G5384484415, G7406577712, G7481328108, G7570540353, Acetazolamide to Improve Obstructive Sleep Apnea and Cardiovascular Outcomes in Young Adults, G9000051603, G9000222291, The Impact of Sleep Disordered Breathing in People who use Opioids, The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome), VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19, Sleep Apnea Endophenotypes: One Size Does Not Fit All
OpenAlex ID: W4412040963